Fulton Breakefield Broenniman LLC purchased a new stake in shares of Anthem Inc (NYSE:ANTM) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 711 shares of the company’s stock, valued at approximately $215,000.

Several other large investors have also modified their holdings of ANTM. Winslow Evans & Crocker Inc. lifted its stake in shares of Anthem by 7.3% in the fourth quarter. Winslow Evans & Crocker Inc. now owns 824 shares of the company’s stock valued at $250,000 after buying an additional 56 shares during the period. Family Legacy Inc. raised its holdings in Anthem by 1.3% in the 4th quarter. Family Legacy Inc. now owns 5,129 shares of the company’s stock valued at $1,577,000 after acquiring an additional 68 shares in the last quarter. Artemis Investment Management LLP raised its holdings in Anthem by 2.1% in the 4th quarter. Artemis Investment Management LLP now owns 369,149 shares of the company’s stock valued at $111,376,000 after acquiring an additional 7,436 shares in the last quarter. Appleton Partners Inc. MA acquired a new position in Anthem in the 4th quarter valued at approximately $242,000. Finally, Allred Capital Management LLC bought a new stake in shares of Anthem in the 4th quarter worth approximately $73,000. 88.14% of the stock is currently owned by institutional investors.

Anthem stock opened at $296.88 on Wednesday. The business has a 50 day simple moving average of $295.40 and a 200 day simple moving average of $277.40. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.70 and a quick ratio of 1.70. The company has a market capitalization of $75.38 billion, a PE ratio of 18.68, a price-to-earnings-growth ratio of 0.86 and a beta of 0.76. Anthem Inc has a one year low of $227.16 and a one year high of $317.99.

Anthem (NYSE:ANTM) last announced its quarterly earnings results on Wednesday, October 23rd. The company reported $4.87 earnings per share for the quarter, beating analysts’ consensus estimates of $4.82 by $0.05. Anthem had a return on equity of 15.59% and a net margin of 4.29%. The firm had revenue of $26.44 billion for the quarter, compared to analysts’ expectations of $25.88 billion. During the same period in the prior year, the business posted $3.81 earnings per share. The business’s revenue was up 15.1% compared to the same quarter last year. Equities analysts anticipate that Anthem Inc will post 19.43 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, December 20th. Stockholders of record on Thursday, December 5th were paid a $0.80 dividend. The ex-dividend date of this dividend was Wednesday, December 4th. This represents a $3.20 annualized dividend and a dividend yield of 1.08%. Anthem’s dividend payout ratio is presently 20.14%.

Several brokerages have recently weighed in on ANTM. Credit Suisse Group lifted their price objective on Anthem from $340.00 to $380.00 and gave the stock an “outperform” rating in a report on Wednesday, January 8th. Evercore ISI upgraded Anthem from an “in-line” rating to an “outperform” rating in a research note on Friday, January 3rd. ValuEngine cut Anthem from a “hold” rating to a “sell” rating in a research report on Tuesday, January 7th. Mizuho started coverage on Anthem in a research report on Thursday, October 17th. They issued a “neutral” rating and a $262.00 target price for the company. Finally, Bank of America downgraded shares of Anthem from a “buy” rating to a “neutral” rating in a research note on Friday, December 6th. One analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $331.00.

In related news, EVP Thomas C. Zielinski sold 10,600 shares of the firm’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $288.33, for a total transaction of $3,056,298.00. Following the completion of the sale, the executive vice president now directly owns 35,247 shares of the company’s stock, valued at approximately $10,162,767.51. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Ronald W. Penczek sold 816 shares of Anthem stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $287.00, for a total value of $234,192.00. Following the completion of the transaction, the chief accounting officer now owns 2,295 shares of the company’s stock, valued at approximately $658,665. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,097 shares of company stock worth $9,503,088. 0.17% of the stock is owned by insiders.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.

Featured Article: How does quantitative easing work?

Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem Inc (NYSE:ANTM).

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.